BTN2A1
Butyrophilin subfamily 2 member A1
Also known as: BT2.1, BT2A1_HUMAN, BTF1, BTN2.1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7KYR7
- Gene
- BTN2A1
- Ensembl
- ENSG00000112763
- Chromosome
- 6
- Canonical length
- 527 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a member of the immunoglobulin superfamily. The gene is located in a cluster of butyrophilin-like genes in the juxta-telomeric region of the major histocompatibility complex on chromosome 6. A pseudogene of this gene has been identified in this cluster. The encoded protein is an integral plasma membrane protein involved in lipid, fatty-acid, and sterol metabolism. Alterations in this gene may be associated with several disease states including metabolic syndrome. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
527 residues, UniProt reviewed canonical sequence.
>Q7KYR7|BTN2A1
1 MESAAALHFS RPASLLLLLL SLCALVSAQF IVVGPTDPIL ATVGENTTLR CHLSPEKNAE
61 DMEVRWFRSQ FSPAVFVYKG GRERTEEQME EYRGRTTFVS KDISRGSVAL VIHNITAQEN
121 GTYRCYFQEG RSYDEAILHL VVAGLGSKPL ISMRGHEDGG IRLECISRGW YPKPLTVWRD
181 PYGGVAPALK EVSMPDADGL FMVTTAVIIR DKSVRNMSCS INNTLLGQKK ESVIFIPESF
241 MPSVSPCAVA LPIIVVILMI PIAVCIYWIN KLQKEKKILS GEKEFERETR EIALKELEKE
301 RVQKEEELQV KEKLQEELRW RRTFLHAVDV VLDPDTAHPD LFLSEDRRSV RRCPFRHLGE
361 SVPDNPERFD SQPCVLGRES FASGKHYWEV EVENVIEWTV GVCRDSVERK GEVLLIPQNG
421 FWTLEMHKGQ YRAVSSPDRI LPLKESLCRV GVFLDYEAGD VSFYNMRDRS HIYTCPRSAF
481 SVPVRPFFRL GCEDSPIFIC PALTGANGVT VPEEGLTLHR VGTHQSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BTN2A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 35 nTPM
- blood vessel: 27 nTPM
- spleen: 26 nTPM
- fallopian tube: 18 nTPM
- lung: 18 nTPM
- urinary bladder: 18 nTPM
Single-cell type
- neutrophils: 86 nCPM
- microglia: 39 nCPM
- nk-cells: 36 nCPM
- vascular smooth muscle cells: 33 nCPM
- breast lactating cells: 33 nCPM
- b-cells: 33 nCPM
Immune cell
- neutrophil: 52 nTPM
- basophil: 44 nTPM
- eosinophil: 30 nTPM
- T-reg: 16 nTPM
- memory CD8 T-cell: 12 nTPM
- gdT-cell: 11 nTPM
Brain region
- cerebellum: 33 nTPM
- hypothalamus: 23 nTPM
- pons: 21 nTPM
- midbrain: 20 nTPM
- medulla oblongata: 17 nTPM
- white matter: 17 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.83
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.44
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B30.2/SPRY domain
- Immunoglobulin domain subtype
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Immunoglobulin-like domain
- Immunoglobulin V-set domain
- Concanavalin A-like lectin/glucanase domain superfamily
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Butyrophilin subfamily 1/2, SPRY/PRY domain
- B30.2/SPRY domain superfamily
- BTN/MOG-like
- Butyrophilin subfamily 3 member A2-like, Ig-C domain
- SPRY domain
- Immunoglobulin V-set domain
- SPRY-associated domain
- Butyrophilin subfamily 3 member A2-like, Ig-C domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BTN2A1 as an antibody target. Whether an autoantibody or antibody against BTN2A1 could matter depends on whether native BTN2A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BTN2A1 is annotated at the cell surface, where native BTN2A1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label BTN2A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...